Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
The Lancet
AUTHOR(S)
Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL
Sep 2013
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
Addiction
AUTHOR(S)
Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL
Welcome to Alkermes Medical Affairs
The resources contained within this website may include educational resources
and information relating to Alkermes, Inc. medicines and therapeutic areas of
interest, congress materials and publications.
This website is intended for U.S. healthcare professionals only.
The content on the website is for personal, educational use only.
No further reproduction or distribution is permitted without
permission from copyright owner(s)
Please confirm below to continue:
Connect with Alkermes Medical Affairs
Message Sent
Sent
Thanks.
This selection will navigate away from Alkermes Medical Affairs.